Log In
BCIQ
Print this Print this
 

CC-31244, CDI-31244

  Manage Alerts
Collapse Summary General Information
Company CoCrystal Pharma Inc.
DescriptionPan-genotypic nonstructural protein 5B (NS5B) non-nucleoside inhibitor (NNI)
Molecular Target
Mechanism of ActionNon-nucleoside polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today